Gene · 407014
Papers3,611
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,611
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Non-invasive diagnostic potential of salivary miR-25-3p for periodontal disease and osteoporosis among a cohort of elderly patients with type 2 diabetes mellitus. | BMC Oral Health | 2023 | 37221590 | PubTator, text mining | PubMed |
Retraction statement: Shao, L., Zhang, X. and Yao, Q. (2020), The F-box protein FBXO11 restrains hepatocellular carcinoma stemness via promotion of ubiquitin-mediated degradation of Snail. FEBS Open Bio, 10: 1810-1820. | FEBS Open Bio | 2023 | 37219054 | PubTator, text mining | PubMed |
| Novel biomarkers for early detection of gastric cancer. | World J Gastroenterol | 2023 | 37213407 | PubTator, text mining | PubMed |
| Expression of mir-25-3p, CARD9 and Surviving in Acute Pancreatitis and Predictive Value for Patient Outcome. | Cell Mol Biol (Noisy-le-grand) | 2023 | 37213160 | PubTator, text mining | PubMed |
| CSNK1D-mediated phosphorylation of HNRNPA2B1 induces miR-25-3p/miR-93-5p maturation to promote prostate cancer cell proliferation and migration through m6A-dependent manner. | Cell Mol Life Sci | 2023 | 37208565 | PubTator, text mining | PubMed |
| Benchmarking blood collection tubes and processing intervals for extracellular vesicle performance metrics. | J Extracell Vesicles | 2023 | 37202906 | PubTator, text mining | PubMed |
| Role of MAGI2-AS3 in malignant and non-malignant disorders. | Pathol Res Pract | 2023 | 37196468 | PubTator, text mining | PubMed |
| Differential Expression of Non-Coding RNAs in Stem Cell Development and Therapeutics of Bone Disorders. | Cells | 2023 | 37190068 | PubTator, text mining | PubMed |
| Circulating Cell-Free Nucleic Acids as Biomarkers for Diagnosis and Prognosis of Pancreatic Cancer. | Biomedicines | 2023 | 37189687 | PubTator, text mining | PubMed |
| Gastric juice non-coding RNAs as potential biomarkers for gastric cancer. | Front Physiol | 2023 | 37179825 | PubTator, text mining | PubMed |
| In Vitro Cell Transformation Assays: A Valuable Approach for Carcinogenic Potentiality Assessment of Nanomaterials. | Int J Mol Sci | 2023 | 37175926 | PubTator, text mining | PubMed |
| TRAF6 Promotes PRMT5 Activity in a Ubiquitination-Dependent Manner. | Cancers (Basel) | 2023 | 37173967 | PubTator, text mining | PubMed |
| Micronutrients/miRs/ATP networking in mitochondria: Clinical intervention with ferroptosis, cuproptosis, and calcium burden. | Mitochondrion | 2023 | 37172668 | PubTator, text mining | PubMed |
| The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms. | Front Pharmacol | 2023 | 37153758 | PubTator, text mining | PubMed |
| Integration of epigenetic regulatory mechanisms in heart failure. | Basic Res Cardiol | 2023 | 37140699 | PubTator, text mining | PubMed |
| Epigenetic Reprogramming via Synergistic Hypomethylation and Hypoxia Enhances the Therapeutic Efficacy of Mesenchymal Stem Cell Extracellular Vesicles for Bone Repair. | Int J Mol Sci | 2023 | 37108726 | PubTator, text mining | PubMed |
| An Insight into the Arising Role of MicroRNAs in Hepatocellular Carcinoma: Future Diagnostic and Therapeutic Approaches. | Int J Mol Sci | 2023 | 37108330 | PubTator, text mining | PubMed |
| Retraction Note: Systematic analyses reveal long non-coding RNA (PTAF)-mediated promotion of EMT and invasion-metastasis in serous ovarian cancer. | Mol Cancer | 2023 | 37106357 | PubTator, text mining | PubMed |
| Non‑coding RNAs: Role of miRNAs and lncRNAs in the regulation of autophagy in hepatocellular carcinoma (Review). | Oncol Rep | 2023 | 37083063 | PubTator, text mining | PubMed |
| Advances in computational frameworks in the fight against TB: The way forward. | Front Pharmacol | 2023 | 37077815 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407014/papers?page=14